About Lumend
Lumend is a company based in Redwood City (United States) founded in 1996 by Matt Selmon and John Simpson was acquired by Cordis in September 2005. Lumend has raised $30.05 million across 4 funding rounds from investors including Cordis, CHL Medical Partners and Morgenthaler. Lumend operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Redwood City, United States
- Founders Matt Selmon, John Simpson
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lumend
Lumend has successfully raised a total of $30.05M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $2 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lumend
Lumend has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Cordis, CHL Medical Partners and Morgenthaler.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage healthcare services investments are facilitated by CHL.
|
Locked | Locked | Locked | |
|
Venture capital and private equity investment firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lumend
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lumend
Investment portfolio details for Lumend
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lumend
Detailed financials for Lumend
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lumend Comparisons
Peer comparison for Lumend
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lumend
Lumend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
|
| Locked | Locked | Locked |
Embolization devices are developed using Shape Memory Polymer foams.
|
|
| Locked | Locked | Locked |
Developer a system for venous arterialization of the lower limbs
|
Detailed competitors of Lumend
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lumend
Complete news archive for Lumend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lumend
Lumend was founded in 1996 and raised its 1st funding round 7 years after it was founded.
Lumend is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Lumend is a funded company, having raised a total of $30.05M across 4 funding rounds to date.
Lumend was founded in 1996 in Redwood City, United States, focusing on medical devices in the cardiovascular sector. Catheter-based technologies are produced and developed to address chronic occlusions in coronary and peripheral artery disease. Devices that aid guide wire placement during invasive procedures, including angioplasty and stenting, are marketed to interventional cardiologists, radiologists, and vascular surgeons. The company was acquired by Cordis in 2005.
Lumend's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Lumend has 7 investors. Key investors include Cordis, CHL Medical Partners, Morgenthaler, De Novo Ventures, and ABS Ventures.